MedTrace Logo

Type 2 Diabetes and Acute Myocardial Infarction

NCT00926133 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 224

Last updated 2009-06-23

No results posted yet for this study

Summary

The present study was designed to determine the prevalence of previously unknown impaired glucose tolerance and type 2 diabetes in patients with acute ST-elevation myocardial infarction subjected to acute PCI. Secondary, a possible association between inflammation, haemostasis and abnormal glucose regulation was studied.

Conditions

Interventions

OTHER

OGTT

Oral glucose tolerance test (diagnostic procedure) eary after an acute STEMI and at three months follow-up.

Sponsors & Collaborators

  • Ullevaal University Hospital

    lead OTHER

Principal Investigators

  • Geir O Andersen, MD, PhD · Ullevaal University Hospital

  • Eva C Knudsen, MD · Ullevaal University Hospital

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2009-08-31
Completion
2009-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00926133 on ClinicalTrials.gov